Furthermore, 27 days post-inoculation, the survival rate (75%) of tumor-bearing mice transplanted with a TREM2-TG-BM was significantly higher than that of WT-BM-transplanted mice (0%) (Fig. 5c). This evidence concerns the gene TREM2 and neoplasm.